Scott Robert Henry Sells 3,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the company’s stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $3.37, for a total value of $10,110.00. Following the sale, the director now owns 141,553 shares of the company’s stock, valued at approximately $477,033.61. This represents a 2.08 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Scott Robert Henry also recently made the following trade(s):

• On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The stock was sold at an average price of $4.64, for a total value of $13,920.00.

NEXGEL Trading Down 2.3 %

NXGL opened at $3.43 on Friday. The company has a market cap of $23.29 million, a P/E ratio of -5.91 and a beta of 0.61. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The company’s 50 day moving average is $3.72 and its 200-day moving average is $3.01. NEXGEL, Inc. has a 1-year low of $1.84 and a 1-year high of $5.10.

Institutional Trading of NEXGEL

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. grew its position in NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 31,848 shares of the company’s stock after acquiring an additional 20,000 shares during the period. Northeast Financial Group Inc. owned 0.50% of NEXGEL worth $82,000 as of its most recent filing with the SEC. 2.21% of the stock is owned by hedge funds and other institutional investors.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.